Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 33,315 shares at $1.97 ($64K) on 2017-11-28, disclosed to the SEC on 2017-11-30.
Open-market purchase of $64k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.97 | 12,395 | $24K | 38.3% |
| 2 | $1.94 | 7,942 | $15K | 24.2% |
| 3 | $1.84 | 12,978 | $24K | 37.5% |
| Total | $1.91 avg | 33,315 | $64K | 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-27 | $352K | — | Filing → |